Wikidata

(Q61054513)

English

Phase II study of NGR-hTNF, a selective vascular targeting agent, in patients with metastatic colorectal cancer after failure of standard therapy

scientific article published on 12 August 2010

In more languages

Statements

title
Phase II study of NGR-hTNF, a selective vascular targeting agent, in patients with metastatic colorectal cancer after failure of standard therapy (English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
20708923
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20708923%20AND%20SRC:MED&resulttype=core&format=json
retrieved
10 February 2020
author name string

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q61054513&oldid=2136743330"